A D LEWIS - JoVE Visualize

Showing results (1-10 of 45) with videos related to

Pageof 5

Sort By:

Trends in Biotechnology|April 1, 1995

Developing animal models for AIDS research--progress and problemsA D Lewis, P R Johnson

Carcinogenesis|July 1, 1988

Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effectsA D Lewis, J D Hayes, C R Wolf

Veterinary Pathology|July 4, 2014

Renal pigmentation due to chronic bismuth administration in a rhesus macaque (Macaca mulatta)A L Johnson, E T Blaine, A D Lewis

Journal of the National Cancer Institute|July 5, 1989

Association of DNA cross-linking with potentiation of the morpholino derivative of doxorubicin by human liver microsomesD H Lau, A D Lewis, B I Sikic

Archives of Dermatology|September 1, 1978

An unusual case of North American blastomycosisD J Pirozzi, S W Schwarzmann, A D Lewis

Journal of the American Veterinary Medical Association|August 1, 1992

Pancreatic adenocarcinoma with metastasis in two ferretsH L Hoefer, A K Patnaik, A D Lewis

Cancer Chemotherapy and Pharmacology|April 2, 1998

Geldanamycin-induced cytotoxicity in human colon-cancer cell lines: evidence against the involvement of c-Src or DT-diaphoraseV G Brunton, G Steele, A D Lewis, et al.

Biochemical Pharmacology|January 7, 1998

Bioreductive metabolism of the novel fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitroimidazolyl) acetamide (SR-4554)E O Aboagye, A D Lewis, M Tracy, et al.

Carcinogenesis|August 1, 1994

Reduction of 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, WIN 59075, SR 4233) to a DNA-damaging species: a direct role for NADPH:cytochrome P450 oxidoreductaseS A Fitzsimmons, A D Lewis, R J Riley, et al.

International Journal of Radiation Oncology, Biology, Physics|January 1, 1992

Sensitization of drug resistant human ovarian cancer cells to cyanomorpholino doxorubicin (MRA-CN) by modulation of glutathione metabolismA D Lewis, G E Durán, D H Lau, et al.

Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:

Pageof 5

Trends in Biotechnology|April 1, 1995

Developing animal models for AIDS research--progress and problemsA D Lewis, P R Johnson

Carcinogenesis|July 1, 1988

Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effectsA D Lewis, J D Hayes, C R Wolf

Veterinary Pathology|July 4, 2014

Renal pigmentation due to chronic bismuth administration in a rhesus macaque (Macaca mulatta)A L Johnson, E T Blaine, A D Lewis

Journal of the National Cancer Institute|July 5, 1989

Association of DNA cross-linking with potentiation of the morpholino derivative of doxorubicin by human liver microsomesD H Lau, A D Lewis, B I Sikic

Archives of Dermatology|September 1, 1978

An unusual case of North American blastomycosisD J Pirozzi, S W Schwarzmann, A D Lewis

Journal of the American Veterinary Medical Association|August 1, 1992

Pancreatic adenocarcinoma with metastasis in two ferretsH L Hoefer, A K Patnaik, A D Lewis

Cancer Chemotherapy and Pharmacology|April 2, 1998

Geldanamycin-induced cytotoxicity in human colon-cancer cell lines: evidence against the involvement of c-Src or DT-diaphoraseV G Brunton, G Steele, A D Lewis, et al.

Biochemical Pharmacology|January 7, 1998

Bioreductive metabolism of the novel fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitroimidazolyl) acetamide (SR-4554)E O Aboagye, A D Lewis, M Tracy, et al.

Carcinogenesis|August 1, 1994

Reduction of 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, WIN 59075, SR 4233) to a DNA-damaging species: a direct role for NADPH:cytochrome P450 oxidoreductaseS A Fitzsimmons, A D Lewis, R J Riley, et al.

International Journal of Radiation Oncology, Biology, Physics|January 1, 1992

Sensitization of drug resistant human ovarian cancer cells to cyanomorpholino doxorubicin (MRA-CN) by modulation of glutathione metabolismA D Lewis, G E Durán, D H Lau, et al.

Pageof 5